Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity.
Guijarro LG, Cano-Martínez D, Toledo-Lobo MV, Ruiz-Llorente L, Chaparro M, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Barreiro-de Acosta M, Vera I, Martín-Arranz MD, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Zoullas S, Monserrat J, Menor-Salvan C, Alvarez-Mon M, Gisbert JP, Ortega MA, Hernández-Breijo B. Guijarro LG, et al. Among authors: cano martinez d. Biomedicines. 2022 Mar 21;10(3):727. doi: 10.3390/biomedicines10030727. Biomedicines. 2022. PMID: 35327530 Free PMC article.
Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved.
Guijarro LG, Cano-Martínez D, Toledo-Lobo MV, Salinas PS, Chaparro M, Gómez-Lahoz AM, Zoullas S, Rodríguez-Torres R, Román ID, Monasor LS, Ruiz-Llorente L, Del Carmen Boyano-Adánez M, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Acosta MB, Vera I, Martín-Arranz MD, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Alvarez-Mon M, Gisbert JP, Ortega MA, Hernández-Breijo B, On Behalf Of The Predicrohn Study Group From Geteccu. Guijarro LG, et al. Among authors: cano martinez d. Biomed Pharmacother. 2021 Dec;144:112239. doi: 10.1016/j.biopha.2021.112239. Epub 2021 Sep 30. Biomed Pharmacother. 2021. PMID: 34601192 Free article.
Effect of Infliximab in oxidised serum albumin levels during experimental colitis.
Cano-Martínez D, Román ID, T Lobo MV, Pastor O, Moreno-Villena I, Paradela A, Hernández-Breijo B, Fernández-Moreno MD, Monserrat J, Sanmartín-Salinas P, Gisbert JP, Guijarro LG. Cano-Martínez D, et al. Biomarkers. 2014 Dec;19(8):693-701. doi: 10.3109/1354750X.2014.982189. Epub 2014 Nov 10. Biomarkers. 2014. PMID: 25382460
Infliximab therapy reverses the increase of allograft inflammatory factor-1 in serum and colonic mucosa of rats with inflammatory bowel disease.
Román ID, Cano-Martínez D, Lobo MV, Fernández-Moreno MD, Hernández-Breijo B, Sacristán S, Sanmartín-Salinas P, Monserrat J, Gisbert JP, Guijarro LG. Román ID, et al. Among authors: cano martinez d. Biomarkers. 2017 Mar;22(2):133-144. doi: 10.1080/1354750X.2016.1252950. Epub 2016 Nov 8. Biomarkers. 2017. PMID: 27781498
Extracellular allograft inflammatory factor-1 (AIF-1) potentiates Th1 cell differentiation and inhibits Treg response in human peripheral blood mononuclear cells from normal subjects.
Cano-Martínez D, Monserrat J, Hernández-Breijo B, Sanmartín Salinas P, Álvarez-Mon M, Val Toledo-Lobo M, Guijarro LG. Cano-Martínez D, et al. Hum Immunol. 2020 Feb-Mar;81(2-3):91-100. doi: 10.1016/j.humimm.2020.01.011. Epub 2020 Feb 11. Hum Immunol. 2020. PMID: 32057519